Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imiquimod vs LLETZ for residual/recurrent CIN2-3
2015-002308-10Phase 2Active
- Start
- Jul 2015
- Modality
- Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of imiquimod in cervical intraepithelial neoplasia (CIN) (2 arms). Started Jul 2015; status: active.
02
Drugs
imiquimod
03
Conditions
cervical intraepithelial neoplasia (CIN)
Beyond the preview
Go deeper on 2015-002308-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002308-10.